Current issues in managing group A streptococcal infections

Advances in Experimental Medicine and Biology

Volumn 549, Issue , 2004, Pages 185-190

  Carapetis, Jonathan R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; IMMUNOGLOBULIN; PENICILLIN G; RIFAMPICIN;

ANTIBIOTIC PROPHYLAXIS; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG EFFICACY; HUMAN; NECROTIZING FASCIITIS; NONHUMAN; PHARYNGITIS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; SYMPTOM; TOXIC SHOCK SYNDROME;

STREPTOCOCCUS; STREPTOCOCCUS SP. 'GROUP A';

EID: 3242790213     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8993-2_25     Document Type: Review

References (32)

1. Andersson, U., Chauvet, J.M., Skansen-Saphir, U., and Andersson, J. (1994). Pooled human IgG modulates cytokine production in lymphocytes and monocytes. J. Immunol. Meth. 175, 201-213.
2. Basma, H., Norrby-Teglund, A., McGeer, A., Low, D.E., El-Ahmedy, O., Dale, J.B., et al. (1998). Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): Potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections. Infect. Immun. 66, 2279-2283.
3. Carapetis, J., Walker, A., Hibble, M., Sriprakash, K., and Currie, B. (1999). Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiol. Infect. 122, 59-65.
4. Cockerill, F.R., 3rd (1998). An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children [Comment]. Pediatrics, 101, 136-140.
5. Danchin, M.H., Curtis, N., Nolan, T.M., and Carapetis, J.R. (2002). Treatment of sore throat in light of the Cochrane verdict: Is the jury still out? Med. J. Austr. 177, 512-515.
6. Darenberg, J., Ihendyane, N., Sjolin, J., Aufwerber, E., Haidl, S., Follin, P. et al., and StreptIg Study Group (2003). Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 37, 333-340.
7. Davies, H., McGeer, A., Schwartz, B., Green, K., Cann, D., Simor, A. et al. (1996). Invasive group A streptococcal infections in Ontario, Canada. N. Engl. J. Med. 335, 547-554.
8. Del Mar, C.B., Glasziou, P.P., and Spinks, A.B. (2001). Antibiotics for sore throat (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley & Sons, Ltd.
9. Elliott, J.A., Butler, J.C., Simon, P.A., Jameson, B.L., Welch, G.E., Facklam, R.R. et al. (1992). Streptococcus pyogenes outbreak in a long-term care facility. Clin. Infect. Dis. 15, 277-284.
10. Fakih, M.G., Hilu, R.C., Savoy-Moore, R.T., and Saravolatz, L.D. (2003). Do resident physicians use antibiotics appropriately in treating upper respiratory infections? A survey of 11 programs. Clin. Infect. Dis. 37, 853-856.
11. Gerber, M.A., Gwaltney, J.M., Jr., Kaplan, E.L., and Schwartz, R.H., Infectious Diseases Society of America, and Bisno, A. L. (2002). Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin. Infect. Dis. 35, 113-125.
12. Hoge, C., Schwartz, B., Talkington, D., Breiman, R., MacNeill, E., and Englender, S. (1993). The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: A retrospective population-based study. JAMA 269, 384-389.
13. Kaplan, E.L. and Johnson, D.R. (2001). Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics 108, 1180-1186.
14. Kaul, R., McGeer, A., Norrby-Teglund, A., Kotb, M., Schwartz, B., O'Rourke, K. et al. (1999). Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - a comparative observational study. The Canadian Streptococcal Study Group. Clin. Infect. Dis. 28, 800-807.
15. Mascini, E.M., Jansze, M., Schouls, L.M., Verhoef, J., and Van Dijk, H. (2001). Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int. J. Antimicrob. Agents 18, 395-398.
16. McGeer, A. and Ontario Group A Streptococcal Study Group (2003). Recommendations for investigation and chemoprophylaxis related to invasive GAS cases, including necrotizing fasciitis and streptococcal toxic shock syndrome. Ontario Group A Streptococcal Study Group, Toronto. Available at http://microbiology.mtsinai.on.ca/protocols/pdf/k5b.pdf
17. McGeer, A., Schwartz, B., Green, K., Cann, D., Simor, A.E., and Low, D.E. (1996). Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. N. Engl. J. Med. 335, 547-554.
18. Muller, M.P., McGeer, A., Low, D.E., and Ontario Group A Streptococcal Study (2001). Successful outcome in six patients treated conservatively for suspected neurotizing fasciitis (NF) due to group A streptococcus (GAS) [abstract]. 41st Intersci. Conf. Antimicro. Agents Chemother. Dec. 2001. Chicago.
19. Norrby-Teglund, A., Kaul, R., Low, D.E., McGeer, A., Andersson, J., Andersson, U. et al. (1996a). Evidence for the presence of streptococcal- superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G. Infect. Immun. 64, 5395-5398.
20. Norrby-Teglund, A., Kaul, R., Low, D.E., McGeer, A., Newton, D.W., Andersson, J. et al. (1996b). Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J. Immunol. 156, 3057-3064.
21. Norrby-Teglund, A. and Low, D.E. (2003). Group A streptococcal toxic shock syndrome and necrotizing fasciitis. Curr. Treat. Options Infect. Dis. 5, 419-429.
22. Ontario Ministry of Health (1995). Guidelines for the management of contacts of cases of invasive group A streptococcal disease (GAS) including streptococcal toxic shock syndrome (STSS) and necrotizing fasciitis. Government of Canada, Ottawa.
23. Prevention of Invasive Group A Streptocccal Infections Working Party (2002). Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: Recommendations from the Centers for Disease Control and Prevention. Clin. Infect. Dis. 35, 950-959.
24. Recco, R.A., Zaman, M.M., Cortes, H., Colucci, J., Poomkudy, G., and Kaplan, E.L. (2002). Intra-familial transmission of life-threatening group A streptococcal infection. Epidemiol. Infect. 129, 303-306.
25. Roy, S., Schreiber, J.R., John, C.C., Kaplan, E.L., Rodriguez, B., Salata, R.A. et al. (2003). A family cluster of five cases of group a streptococcal pneumonia. Pediatrics 112, 61-615.
26. Royal College of Paediatrics and Child Health (2000). RCPCH, Guidelines for Good Practice. London.
27. Schwartz, B. and anonymous (1999). Nosocomial group A streptococcal infections associated with asymptomatic health-care workers - Maryland and California, 1997. Adv. Pediatr. Infect. Dis. 14, 129-145.
28. Stevens, D.L. (2003). Dilemmas in the treatment of invasive Streptococcus pyogenes infections. Clin. Infect. Dis. 37, 341-343.
29. Stevens, D.L., Gibbons, A.E., Bergstrom, R., and Winn, V. (1988). The Eagle effect revisited: Efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J. Infect. Dis. 158, 23-28.
30. Stevens, D.L., Yan, S., and Bryant, A.E. (1993). Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: An explanation for the inoculum effect. J. Infect. Dis. 167, 1401-1405.
31. Tanz, R.R., Poncher, J.R., Corydon, K.E., Kabat, K., Yogev, R., and Shulman, S.T. (1991). Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J. Pediatr. 119, 123-128.
32. Tanz, R.R., Shulman, S.T., Barthel, M.J., Willert, C., and Yogev, R. (1985). Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J. Pediatr. 106, 876-880.